We are live on ! Find out more
TIL icon

Instil Bio
TIL

40 hedge funds and large institutions have $100M invested in Instil Bio in 2024 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 19 increasing their positions, 3 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

533% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 3

1.6% less ownership

Funds ownership: 81.82% → 80.22% (-1.6%)

18% less funds holding

Funds holding: 49 → 40 (-9)

40% less funds holding in top 10

Funds holding in top 10: 5 → 3 (-2)

50% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 18

72% less capital invested

Capital invested by funds: $358M → $100M (-$258M)

Holders
40
Holders Change
-9
Holders Change %
-18.37%
% of All Funds
0.53%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.04%
New
9
Increased
19
Reduced
3
Closed
18
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$3.87M
2
UBS Group
UBS Group
Switzerland
+$2.77M
3
O
OrbiMed
New York
+$2.53M
4
BCM
BML Capital Management
Indiana
+$1.98M
5
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$1.91M

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$23.3M
2
CC
Commodore Capital
New York
-$10.2M
3
Invesco
Invesco
Georgia
-$9.77M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$6.43M
5
APM
Avidity Partners Management
Texas
-$1.96M
Name Holding Trade Value Shares
Change 		Change in
Stake
CVV
1
Curative Ventures V
Texas
$36.3M – – –
VC
2
Vivo Capital
California
$11.2M -$1.18M -38,854 -6%
CI
3
CPMG Inc
Texas
$7.84M – – –
BCM
4
BML Capital Management
Indiana
$7.64M +$1.98M +65,000 +19%
BCM
5
Boxer Capital Management
California
$6.79M +$10.8M +355,500 New
SL
6
Siren LLC
Connecticut
$3.67M – – –
Vanguard Group
7
Vanguard Group
Pennsylvania
$2.89M – – –
SCM
8
Superstring Capital Management
New York
$2.83M +$1.23M +40,472 +38%
Renaissance Technologies
9
Renaissance Technologies
New York
$2.55M +$1.13M +36,900 +38%
Goldman Sachs
10
Goldman Sachs
New York
$2.42M +$3.87M +126,927 New
O
11
OrbiMed
New York
$2.23M +$2.53M +83,085 +247%
UBS Group
12
UBS Group
Switzerland
$1.74M +$2.77M +90,955 +69,431%
Assenagon Asset Management
13
Assenagon Asset Management
Luxembourg
$1.19M +$1.91M +62,558 New
Balyasny Asset Management
14
Balyasny Asset Management
Illinois
$1.18M +$1.35M +44,411 +258%
BlackRock
15
BlackRock
New York
$1.14M +$213K +6,973 +13%
Dimensional Fund Advisors
16
Dimensional Fund Advisors
Texas
$1.11M +$1.46M +47,989 +482%
Millennium Management
17
Millennium Management
New York
$1.02M +$1.62M +53,253 New
Adage Capital Partners
18
Adage Capital Partners
Massachusetts
$955K +$1.52M +50,000 New
Geode Capital Management
19
Geode Capital Management
Massachusetts
$797K +$48.9K +1,604 +4%
Morgan Stanley
20
Morgan Stanley
New York
$688K +$950K +31,169 +640%
6CM
21
683 Capital Management
New York
$660K +$1.05M +34,557 New
VA
22
VR Adviser
New York
$633K – – –
ACM
23
ADAR1 Capital Management
Texas
$605K +$244K +8,001 +34%
FAM
24
Fred Alger Management
New York
$598K -$549 -18 -0.1%
Marshall Wace
25
Marshall Wace
United Kingdom
$452K +$8.29K +272 +1%
1
2 3

TIL Hedge Fund Activity: Q4 2024 in Review

40 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Instil Bio (TIL) for Q4 2024, worth a combined $100M — down 72% from $358M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of TIL and 9 opened new positions — a net loss of 9 holders — while 3 trimmed existing stakes and 19 added.

The largest buyer was Goldman Sachs, opening a new position worth an estimated $3.87M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $23.3M sold.

  • 40 institutional investors held Instil Bio (TIL) as of Q4 2024, down from 49 in Q3 2024.
  • Funds reported $100M of Instil Bio stock for Q4 2024, down 72% quarter-over-quarter.
  • 9 funds opened new Instil Bio positions in Q4 2024 and 18 closed out, a net change of -9 holders.
  • The largest Instil Bio buyer in Q4 2024 was Goldman Sachs, an estimated $3.87M added.
  • The largest Instil Bio seller in Q4 2024 was Perceptive Advisors, an estimated $23.3M sold.

Based on aggregated 13F filings for Q4 2024.